COVID-19 challenge for Industries


Pharmaceutical and biological engineers are also helping produce faster and cheaper diagnostic solutions, repurposing and developing new drugs to treat patients, isolating antibodies against the present coronavirus, and testing new vaccines. Janssen Research & Development and Moderna are accelerating the development of potential vaccines, while a team at the Wyss Institute is developing a surrogate non-COVID coronavirus for use in studies.



Meanwhile, services companies such as Ginkgo Bioworks and Twist Biosciences have offered their platform to help support technology development. And universities are putting research on hold and shifting their focus to COVID-19. In the upcoming May CEP, you can read an article that describes such work underway at Rensselaer Polytechnic Institute (RPI).


    Related Conference of COVID-19 challenge for Industries

    April 07-08, 2025

    15th World Congress on Chemistry

    Vancouver, Canada
    May 14-15, 2025

    17th International Conference on Clinical Chemistry

    Toronto, Canada
    June 26-27, 2025

    14th World Congress on Chromatography

    Paris, France
    August 18-19, 2025

    14th World Congress on Biopolymers and Biomaterials

    Valencia, Spain
    September 22-23, 2025

    21st European Organic Chemistry Congress

    Dubai, UAE
    October 27-28, 2025

    15th International Chemistry Congress

    London, UK
    November 06-07, 2025

    6th World Expo on Biopolymers and Bioplastics

    Dubai, UAE
    December 08-09, 2025

    5th International Conference on Analytical Chemistry

    Rome, Italy

    COVID-19 challenge for Industries Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in